USPTO serial 98434174
INGENUITY
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- SPARACINO, MARK V
- Law office
- TMEG LAW OFFICE 103
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INGENUITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for scientific and scientific research use; protein in raw material form for scientific, medical and veterinary research; biological reagents for scientific, medical or veterinary research use, namely, vectors for scientific and research use; biological reagents for scientific, medical or veterinary research use, namely, lentiviral vectors for scientific and research use; chemicals for use in the manufacture of vectors and lentiviral vectors; chemicals for use in gene therapy research | ACTIVE | — |
| 005 | Pharmaceutical preparations, namely, therapeutics and prophylactic preparations for medical and veterinary purposes in the field of gene therapy; biological reagents for medical and veterinary use, namely, vectors and lentiviral vectors for therapeutic and prophylactic purposes; biological reagents for medical and veterinary use, namely, vectors and lentiviral vectors for use in gene therapy; pharmaceutical preparations, namely, therapeutic and prophylactic preparations for gene therapy; pharmaceutical preparations, namely, therapeutic preparations for treating respiratory disorders and diseases; pharmaceutical preparations, namely, prophylactic preparations for preventing respiratory disorders and diseases; platform technologies being drug delivery agents in the form of lentiviral vectors for treating respiratory disorders and diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 24, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 11, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 7, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 6, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 6, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 6, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 22, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 22, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 2, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 26, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 26, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 26, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 13, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 20, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 20, 2024 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 20, 2024 | ALIE | ASSIGNED TO LIE | — |
| Mar 6, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Mar 5, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 5, 2024 | NWAP | NEW APPLICATION ENTERED | — |